Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription

Articles published in Oncogene

Retrieve available abstracts of 47 articles:
HTML format

Single Articles

    November 2021
  1. SUN L, Xi S, Zhou Z, Zhang F, et al
    Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor.
    Oncogene. 2021 Nov 29. pii: 10.1038/s41388-021-02130.
    PubMed     Abstract available

    September 2021
  2. LI B, Xia Y, Lv J, Wang W, et al
    miR-151a-3p-rich small extracellular vesicles derived from gastric cancer accelerate liver metastasis via initiating a hepatic stemness-enhancing niche.
    Oncogene. 2021 Sep 17. pii: 10.1038/s41388-021-02011.
    PubMed     Abstract available

    August 2021
  3. QIU P, Hou W, Wang H, Lei KKW, et al
    Sirt1 deficiency upregulates glutathione metabolism to prevent hepatocellular carcinoma initiation in mice.
    Oncogene. 2021 Aug 25. pii: 10.1038/s41388-021-01993.
    PubMed     Abstract available

    July 2021
  4. LIU Z, Wang A, Pu Y, Li Z, et al
    Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach.
    Oncogene. 2021 Jul 30. pii: 10.1038/s41388-021-01976.
    PubMed     Abstract available

  5. ZHANG Y, Yan Q, Gong L, Xu H, et al
    Correction: C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
    Oncogene. 2021 Jul 26. pii: 10.1038/s41388-021-01942.

  6. BRAHMA MK, Gilglioni EH, Zhou L, Trepo E, et al
    Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges.
    Oncogene. 2021 Jul 21. pii: 10.1038/s41388-021-01950.
    PubMed     Abstract available

  7. ZHANG EB, Zhang X, Wang K, Zhang F, et al
    Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis.
    Oncogene. 2021 Jul 10. pii: 10.1038/s41388-021-01934.
    PubMed     Abstract available

    June 2021
  8. LIN YH, Wu MH, Liu YC, Lyu PC, et al
    LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing.
    Oncogene. 2021 Jun 17. pii: 10.1038/s41388-021-01905.
    PubMed     Abstract available

  9. WANG S, Cao K, Liao Y, Zhang W, et al
    CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01855.
    PubMed     Abstract available

  10. WANG X, Dong J, Li X, Cheng Z, et al
    CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01867.
    PubMed     Abstract available

  11. SHEN M, Zhang R, Jia W, Zhu Z, et al
    Nuclear scaffold protein p54(nrb)/NONO facilitates the hypoxia-enhanced progression of hepatocellular carcinoma.
    Oncogene. 2021 Jun 2. pii: 10.1038/s41388-021-01848.
    PubMed     Abstract available

    May 2021
  12. CAROTTI S, Zingariello M, Francesconi M, D'Andrea L, et al
    Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge.
    Oncogene. 2021 May 20. pii: 10.1038/s41388-021-01824.
    PubMed     Abstract available

    April 2021
  13. CHEN S, Du Y, Xu B, Li Q, et al
    Vaccinia-related kinase 2 blunts sorafenib's efficacy against hepatocellular carcinoma by disturbing the apoptosis-autophagy balance.
    Oncogene. 2021 Apr 19. pii: 10.1038/s41388-021-01780.
    PubMed     Abstract available

  14. CHEN K, Hou Y, Liao R, Li Y, et al
    LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1.
    Oncogene. 2021 Apr 6. pii: 10.1038/s41388-021-01671.
    PubMed     Abstract available

    March 2021
  15. ZHANG G, Yang Y, Hu H, Liu K, et al
    Energy stress-induced linc01564 activates the serine synthesis pathway and facilitates hepatocellular carcinogenesis.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01749.
    PubMed     Abstract available

  16. JING CY, Fu YP, Zhou C, Zhang MX, et al
    Hepatic stellate cells promote intrahepatic cholangiocarcinoma progression via NR4A2/osteopontin/Wnt signaling axis.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01705.
    PubMed     Abstract available

  17. PAN Z, Liu C, Zhi Y, Xie Z, et al
    LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation.
    Oncogene. 2021 Mar 8. pii: 10.1038/s41388-021-01736.
    PubMed     Abstract available

  18. ALASADI A, Cao B, Guo J, Tao H, et al
    Mitochondrial uncoupler MB1-47 is efficacious in treating hepatic metastasis of pancreatic cancer in murine tumor transplantation models.
    Oncogene. 2021 Mar 1. pii: 10.1038/s41388-021-01688.
    PubMed     Abstract available

    February 2021
  19. LUO JH, Liu S, Tao J, Ren BG, et al
    Pten-NOLC1 fusion promotes cancers involving MET and EGFR signalings.
    Oncogene. 2021;40:1064-1076.
    PubMed     Abstract available

    January 2021
  20. LU Y, Li X, Liu H, Xue J, et al
    beta-Trcp and CK1delta-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01596.
    PubMed     Abstract available

    December 2020
  21. ZHANG Y, Yan Q, Gong L, Xu H, et al
    C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
    Oncogene. 2020 Dec 15. pii: 10.1038/s41388-020-01593.
    PubMed     Abstract available

    November 2020
  22. YAO L, Xuan Y, Zhang H, Yang B, et al
    Reciprocal REGgamma-mTORC1 regulation promotes glycolytic metabolism in hepatocellular carcinoma.
    Oncogene. 2020 Nov 23. pii: 10.1038/s41388-020-01558.
    PubMed     Abstract available

  23. YU J, Wang N, Gong Z, Liu L, et al
    Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma.
    Oncogene. 2020 Nov 12. pii: 10.1038/s41388-020-01545.
    PubMed     Abstract available

    October 2020
  24. LIU C, Zhou X, Long Q, Zeng H, et al
    Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01521.
    PubMed     Abstract available

  25. NIMMAKAYALA RK, Leon F, Rachagani S, Rauth S, et al
    Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01518.
    PubMed     Abstract available

  26. CHEN J, Xuan Z, Song W, Han W, et al
    EAG1 enhances hepatocellular carcinoma proliferation by modulating SKP2 and metastasis through pseudopod formation.
    Oncogene. 2020 Oct 24. pii: 10.1038/s41388-020-01522.
    PubMed     Abstract available

  27. VON FELDEN J, Craig AJ, Garcia-Lezana T, Labgaa I, et al
    Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma.
    Oncogene. 2020 Oct 23. pii: 10.1038/s41388-020-01519.
    PubMed     Abstract available

  28. GAMAEV L, Mizrahi L, Friehmann T, Rosenberg N, et al
    The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.
    Oncogene. 2020 Oct 22. pii: 10.1038/s41388-020-01513.
    PubMed     Abstract available

  29. YAN Y, Huang P, Mao K, He C, et al
    Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression.
    Oncogene. 2020 Oct 13. pii: 10.1038/s41388-020-01498.
    PubMed     Abstract available

  30. HE Q, Lin Z, Wang Z, Huang W, et al
    SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
    Oncogene. 2020 Oct 12. pii: 10.1038/s41388-020-01500.
    PubMed     Abstract available

    September 2020
  31. SUN Z, Xue S, Zhang M, Xu H, et al
    Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma.
    Oncogene. 2020 Sep 25. pii: 10.1038/s41388-020-01475.
    PubMed     Abstract available

  32. YANG B, Feng X, Liu H, Tong R, et al
    High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
    Oncogene. 2020 Sep 11. pii: 10.1038/s41388-020-01450.
    PubMed     Abstract available

  33. ZHOU Q, Huang T, Jiang Z, Ge C, et al
    Correction: Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
    Oncogene. 2020 Sep 7. pii: 10.1038/s41388-020-01440.
    PubMed     Abstract available

    August 2020
  34. WU D, Wang Y, Yang G, Zhang S, et al
    A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27.
    Oncogene. 2020 Aug 18. pii: 10.1038/s41388-020-01417.
    PubMed     Abstract available

  35. BARTOLOME RA, Pintado-Berninches L, Jaen M, de Los Rios V, et al
    SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166.
    Oncogene. 2020 Aug 15. pii: 10.1038/s41388-020-01419.
    PubMed     Abstract available

    July 2020
  36. SHI X, Liu TT, Yu XN, Balakrishnan A, et al
    microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
    Oncogene. 2020 Jul 27. pii: 10.1038/s41388-020-01401.
    PubMed     Abstract available

  37. FENG H, Liu J, Qiu Y, Liu Y, et al
    RNA-binding motif protein 43 (RBM43) suppresses hepatocellular carcinoma progression through modulation of cyclin B1 expression.
    Oncogene. 2020 Jul 6. pii: 10.1038/s41388-020-1380.
    PubMed     Abstract available

    May 2020
  38. TSAI CN, Yu SC, Lee CW, Pang JS, et al
    SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo.
    Oncogene. 2020 May 13. pii: 10.1038/s41388-020-1319.
    PubMed     Abstract available

  39. HUANG WJ, Tian XP, Bi SX, Zhang SR, et al
    The beta-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis.
    Oncogene. 2020 May 5. pii: 10.1038/s41388-020-1307.
    PubMed     Abstract available

  40. ZHANG C, Huang S, Zhuang H, Ruan S, et al
    YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
    Oncogene. 2020 May 4. pii: 10.1038/s41388-020-1303.
    PubMed     Abstract available

  41. WILLIAMS M, Liu X, Zhang Y, Reske J, et al
    NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21(WAF1/CIP1) overexpression, which is reversed by metformin.
    Oncogene. 2020;39:3821-3836.
    PubMed     Abstract available

    April 2020
  42. TIAN L, Yao K, Liu K, Han B, et al
    PLK1/NF-kappaB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression.
    Oncogene. 2020;39:3145-3162.
    PubMed     Abstract available

    March 2020
  43. HSU BE, Roy J, Mouhanna J, Rayes RF, et al
    C3a elicits unique migratory responses in immature low-density neutrophils.
    Oncogene. 2020;39:2612-2623.
    PubMed     Abstract available

  44. XIAO Y, Liu G, Sun Y, Gao Y, et al
    Targeting the estrogen receptor alpha (ERalpha)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion.
    Oncogene. 2020;39:2493-2508.
    PubMed     Abstract available

  45. SAKSOUK N, Hajdari S, Perez Y, Pratlong M, et al
    The mouse HP1 proteins are essential for preventing liver tumorigenesis.
    Oncogene. 2020;39:2676-2691.
    PubMed     Abstract available

    February 2020
  46. DAI K, Tanaka M, Kamiyoshi A, Sakurai T, et al
    Deficiency of the adrenomedullin-RAMP3 system suppresses metastasis through the modification of cancer-associated fibroblasts.
    Oncogene. 2020;39:1914-1930.
    PubMed     Abstract available

    January 2020
  47. OUAHOUD S, Voorneveld PW, van der Burg LRA, de Jonge-Muller ESM, et al
    Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancer.
    Oncogene. 2020 Jan 23. pii: 10.1038/s41388-020-1157.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.